openPR Logo
Press release

Global Breast Cancer Therapeutics Market to reach USD 16 billion by 2023

03-21-2017 08:22 AM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Global Market Insights, Inc.

Global Market Insights, Inc.

Breast Cancer Therapeutics Market is witnessing exponential growth in coming years as breast cancer the most widespread disease in women. According to WHO statistics, it is the second most prevalent type of the disease globally, and the most widespread type in females. In women, it accounts for 20% of all invasive and 13% of all female cancers, and is responsible for 15% of all deaths caused by the disease globally, including both females and males. Every year, around 200,000 new cases in women and nearly 2,000 new cases in men are diagnosed.

Breast Cancer Therapeutics Market size was valued at over USD 7.5 billion in 2015 and is expected to witness growth to surpass USD 16 billion by 2023.

Request for a table of content of this report -

China breast cancer therapeutics market share accounted for over 15% of the Asia Pacific revenue. Australia accounted for over 10% and India contributed 3% to overall revenue generation, with the latter expected to grow at 9% CAGR over the forecast timeframe.

This disease occurs when cells in the breast show uncontrolled growth. Malignant tumors may metastatize or growing into the surrounding tissues. It generally either begins in the lobules, which are the milk producing glands, or the inner lining of ducts, the passage that supply milk from lobules. Tumor occurring in the lobules is lobular carcinoma which represents 80% to 90% of all cases, while one which develops from the ducts is ductal carcinoma, representing 10% to 20% of all cases.

In developed countries, the rates are much higher compared to their developing counterparts. However, in many developing nations, it is now rising abruptly due to changes in lifestyle, reproductive factors, and increased life expectancy. Mortality from breast cancer is a leading cause of death among women in developing countries, as well as in the developed world. Approximately 85% to 90% of all cases are caused by genetic abnormality, while the remaining are due to inherited abnormalities.

To access sample pages or view this report titled, “Breast Cancer Therapeutics Market Size, Industry Analysis Report, Regional Outlook (U.S., Germany, UK, Italy, Russia, China, India, Japan, South Korea, Brazil, Mexico, Saudi Arabia, UAE, South Africa), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023” in detail along with the table of contents, please click on the link below:

High degree of competition, potential side effects, growing number of medication options, and substitute branded drugs availability may adversely impact revenue in the coming years. On the basis of drug class, the industry is categorized into five major segments, namely, anti-metabolites, HER2 inhibitors, aromatase inhibitors, mitotic inhibitors, and hormone receptors.

Based on the clinical study, the breast cancer therapeutics market can be segmented into Phase I, Phase II, and Phase III drugs. Of these, Phase III drugs are BKM120, Palbociclib (PD-0332991) + Exemestane, Neratinib, DOXIL, ABP 980, NKTR-102, NK105, CT-P6, and Olaparib. Neratinib (developed by Puma Biotechnology), a clinical trial phase IIIdrug, will generate maximum revenue by 2023. It is highly powerful as an irreversible tyrosine kinase inhibitor (TKI).

Pfizer’s palbociclib with fulvestrant contributed considerably to global breast cancer therapeutics market size. In 2015, the company announced that the U.S. Food and Drug Administration (FDA) approved the use of Ibrance (palbociclib). In February 2015, Ibrance was approved and indicated for the treatment of HER2-, HR+ metastatic or advanced breast cancer in amalgamation with letrozole as initial endocrine-based therapy done in postmenopausal women. Ibrance is the only cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor approved by the FDA which benefits patients as a first line therapy (along with letrozole).

Make an inquiry for buying this report @

Available products comprise a wide range of treatment options, including hormonal, combination, targeted and chemotherapies. Chemotherapy remains the most important class of drugs for treatment; however, the trend of using targeted drugs is on the rise. Treatment for the disease has been modernized in the past decades with increasing usage of targeted therapies. Perpendicular rise in the occurrence of disease makes it an industry where novel molecules and therapies are imperative. Industry novel products include Halaven, a chemotherapeutic agent; Kadcyla, a human antibody-drug conjugate, and Perjeta, a targeted therapy.

Key players in the breast cancer therapeutics market include AstraZeneca, Eisai, Eli Lilly and Company, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis International AG, Pfizer, Puma Biotechnology, Sanofi S.A., and Teva Pharmaceutical Industries. Genentech contributed over 60% to the overall breast cancer therapeutics market share in 2015.

Browse Related Reports:

• Cancer Biological Therapy Market Size By Product (Monoclonal Antibodies [Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bi-Specific Monoclonal Antibodies], Vaccines [Preventive, Therapeutic], Cancer Growth Blockers [Tyrosine Kinase Inhibitors, Proteasome Inhibitors, mTOR Inhibitors], Blood Cell Growth Factors [Lenograstim, Filgrastim], Cytokines [Interferons, Interleukins]), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Breast Cancer Therapeutics Market to reach USD 16 billion by 2023 here

News-ID: 475873 • Views: 497

More Releases from Global Market Insights, Inc.

Rare Sugar Market Top 3 Trends, Covid-19 Outbreak, Factors Driving, Threats, Cha …
Rising awareness regarding health & fitness and the subsequent shift in consumer trends towards low-calorie sweeteners will boost rare sugar market share over the forecast spell. Recent years have marked a steady rise in the prevalence of cardiovascular ailments, diabetes, and obesity, among other chronic conditions, which have triggered a massive change in consumer perceptions towards health. This in turn has led to a surge in demand for various functional foods
Global Selenium Yeast Market Industry Assessment, Trends, Competitive Landscape, …
The selenium yeast market is anticipated to register substantial gains on account of rising inclination towards organic additives in animal nutrition, with an aim to improve livestock health and production. Consumers are steadily becoming aware of the downsides associated with using synthetic additives. As a result, they are preferring selenium yeast feed grades over other counterparts to provide balanced nutrition to their livestock. According to Global Market Insights Inc estimates
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key pl …
Global Power Distribution Component Market Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight. Request a sample of this research report @ Voltage rating have acted as a standard industry protocol toward the installation of power components reliant on regulatory preference, deployment areas, and the group
Prenatal Vitamin Ingredients Market New Entrants, Risk Factors, Market Expansion …
The rise in the instances of miscarriages on account of poor diet and hygiene will anchor the consumption of prenatal vitamin ingredients. Excessive intake of junk food has resulted in the scarcity of important nutrients in pregnant women that could adversely affect the fetus health and development. Furthermore, prenatal vitamin ingredients possess additional nutritional components that are not so easily sourced from regular food items and products. Prenatal vitamin ingredients can

All 5 Releases

More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top